The utility of histopathological features predicting microsatellite high (MSI-H) colorectal cancer in a limited setting

被引:0
|
作者
Horpaopan, Sukanya [1 ]
Somran, Julintorn [2 ]
机构
[1] Naresuan Univ, Dept Anat, Fac Med Sci, Phitsanulok 65000, Thailand
[2] Naresuan Univ, Dept Pathol, Fac Med, Phitsanulok 65000, Thailand
关键词
Colorectal cancer (CRC); microsatellite instability (MSI); histopathology; mismatch repair (MMR) genes; LYNCH-SYNDROME; MOLECULAR CHARACTERISTICS; COLON-CANCER; INSTABILITY; CRITERIA; TUMORS; BAT26;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Colorectal cancer (CRC) is one of the most common cancers worldwide. Approximately 15% of CRCs have microsatellite instability (MSI), which is caused by a dysfunction of the DNA mismatch repair (MMR) genes. The histopathological features have been applied to predict high frequency MSI (MSI-H) in CRCs, and we investigated this association with MSI-H and the histopathological features. Materials and methods: Fifty-four tumors were evaluated based on nine histopathological features associated with MSI-H. DNA was extracted and prepared from the FFPE of tumors and normal colon tissue. Five microsatellite markers (BAT25, BAT26, D2S123, D5S346, and D17S250) were screened. Results: Of the 54 cases, 38 (70.4%) were between 50-60 years old, and 16 (29.6%) were younger than 50 years. Tumors mainly presented in the left-side colon (40 cases, 74.1%). MSI-high (MSI-H) was found in 7 cases, MSI-low (MSI-L) was found in 7 cases, and the rest were microsatellite stable (MSS). The majority of CRC with MSI-H showed a Crohn-like lymphocytic reaction, mucinous features, tumor grade 2, and tumor-infiltrating lymphocytes. Only the mucinous component was significantly associated with the MSI-H (P < 0.05). Conclusion: The initial prevalence of MSI-CRCs in our study (via 5 microsatellite markers) was similar to previous studies. Some histopathological features helped to guide the MSI testing. Even though only the mucinous features were related to the MSI-H status, none of MSI-H CRCs lacked any of the of 9 selected histopathological features. Our study was limited by selected age groups and a small sample size. Further studies with more samples including all age groups should be performed to demonstrate the usefulness of the histopathological features in predicting the MSI in CRC.
引用
收藏
页码:1878 / 1887
页数:10
相关论文
共 50 条
  • [1] The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
    Janindra Warusavitarne
    Margaret Schnitzler
    International Journal of Colorectal Disease, 2007, 22 : 739 - 748
  • [2] The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
    Warusavitarne, Janindra
    Schnitzler, Margaret
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (07) : 739 - 748
  • [3] Is MSI-H of value in predicting the development of metachronous colorectal cancer?
    Lawes, DA
    Pearson, T
    SenGupta, S
    Boulos, PB
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) : 473 - 476
  • [4] Clinicopathological features of microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in Japanese patients.
    Kawazoe, Akihito
    Shitara, Kohei
    Noguchi, Masaaki
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC.
    Diaz, Luis A.
    Marabelle, Aurelien
    Delord, Jean-Pierre
    Shapira-Frommer, Ronnie
    Geva, Ravit
    Peled, Nir
    Kim, Tae Won
    Andre, Thierry
    Van Cutsenn, Eric
    Guimbaud, Rosine
    Jaeger, Dirk
    Elez, Elena
    Yoshino, Takayuki
    Joe, Andrew K.
    Lam, Baohoang
    Gause, Christine K.
    Pruitt, Scott Knowles
    Kang, S. Peter
    Le, Dung T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] SURVIVAL OUTCOMES IN METASTATIC COLORECTAL CANCER (CRC) WITH HIGH-LEVEL MICROSATELLITE INSTABILITY (MSI-H)
    Overman, M. J.
    Kopetz, S.
    Wong, S.
    Tie, J.
    Kosmider, S.
    Jacob, A.
    Vilar, E.
    Gibbs, P.
    Desai, J.
    Tran, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 220 - 221
  • [7] Clinicopathologic Features of Microsatellite Instability-High (MSI-H) Colorectal Carcinomas in Patients &gt;60 Years of Age
    Hu, H.
    Hartman, D. J.
    Brand, R. E.
    Bahary, N.
    Dudley, B.
    Chiosea, S. I.
    Nikiforova, M. N.
    Pai, R. K.
    LABORATORY INVESTIGATION, 2013, 93 : 155A - 155A
  • [8] Histologic Subtypes of Microsatellite Instability-High (MSI-H) Colorectal Adenocarcinomas (CRCs) and Their Association with Clinicopathologic Features and Prognosis
    Agarwal, A.
    Sethi, S.
    Lin, E.
    Luthra, R.
    Rashid, A.
    Hamilton, S. R.
    Eng, C.
    Maru, D. M.
    MODERN PATHOLOGY, 2010, 23 : 134A - 134A
  • [9] KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer.
    Le, Dung T.
    Kavan, Petr
    Kim, Tae Won
    Burge, Matthew E.
    Van Cutsem, Eric
    Hara, Hiroki
    Boland, Patrick McKay
    Van Laethem, Jean-Luc
    Geva, Ravit
    Taniguchi, Hiroya
    Crocenzi, Todd S.
    Sharma, Manish
    Atreya, Chloe Evelyn
    Diaz, Luis A.
    Liang, Li Wen
    Marinello, Patricia
    Dai, Tong
    O'Neil, Bert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Clinicopathologic Features of Microsatellite Instability-High (MSI-H) Colorectal Carcinomas in Patients &gt;60 Years of Age
    Hu, H.
    Hartman, D. J.
    Brand, R. E.
    Bahary, N.
    Dudley, B.
    Chiosea, S. I.
    Nikiforova, M. N.
    Pai, R. K.
    MODERN PATHOLOGY, 2013, 26 : 155A - 155A